Vistin Pharma ASA (LON:0RAM)

Market Cap	72.73M -1.3%
Revenue (ttm)	33.91M +6.7%
Net Income	5.81M +27.2%
EPS	0.13 +27.2%
Shares Out	n/a
PE Ratio	12.51
Forward PE	n/a
Dividend	0.09 (0.43%)
Ex-Dividend Date	Jun 4, 2025

Volume	22
Average Volume	723
Open	21.35
Previous Close	20.20
Day's Range	21.35 - 21.35
52-Week Range	20.20 - 26.70
Beta	1.03
RSI	42.27
Earnings Date	Feb 12, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1969
• Employees: 75
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAM

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial numbers in NOK